Welcome to our dedicated page for Avanos Medical news (Ticker: AVNS), a resource for investors and traders seeking the latest updates and insights on Avanos Medical stock.
Avanos Medical, Inc. (NYSE: AVNS) delivers innovative medical device solutions addressing critical healthcare challenges in pain management, recovery, and digestive health. This page provides investors and industry professionals with timely updates on the company’s latest developments, strategic initiatives, and clinical advancements.
Access official press releases, earnings reports, and regulatory filings alongside analysis of product launches and partnerships. Track Avanos Medical’s progress in advancing non-opioid therapies and life-sustaining nutritional support systems designed for hospital and home care settings.
Key updates include developments in cold compression technology, feeding tube innovations, and operational efficiency initiatives under the company’s ongoing transformation. All content is sourced directly from Avanos Medical and verified financial disclosures to ensure accuracy.
Bookmark this page for streamlined access to AVNS news that impacts clinical practice and investment decisions. Check regularly for updates on breakthrough medical technologies and their global healthcare applications.
Avanos Medical reported Q1 2021 results, with net sales of $181 million, unchanged year-over-year. The company experienced a net loss of $8 million, contrasting with a net income of $4 million last year. Adjusted net income rose to $11 million from $8 million. Gross margin decreased to 51% from 57%, primarily due to increased freight costs. The company expects 2021 net sales to increase by 2 to 4% and projects adjusted diluted earnings per share between $1.10 and $1.25. Free cash flow was an outflow of $9 million.
Avanos Medical will host a conference call on May 7, 2021, at 9 a.m. ET, to discuss its financial results for the first quarter of 2021. A news release detailing these results will be issued before market opening that day. The call will be led by CEO Joe Woody and CFO Michael Greiner. Investors can join by dialing 877-240-5772 in the U.S. A replay will be available starting at noon ET on the same day. Avanos Medical focuses on innovative medical solutions, aiming to reduce opioid use and enhance patient recovery.
Avanos Medical, Inc. (NYSE: AVNS) will have CEO Joe Woody present at the Virtual KeyBanc Life Sciences & MedTech Investor Forum on March 23, 2021, at approximately 2 p.m. ET. A live webcast of the presentation can be accessed in the Investors section of Avanos Medical's website, where it will also be archived. Avanos Medical is dedicated to enhancing patient care and reducing opioid use through innovative medical devices.
Avanos Medical (NYSE: AVNS) announced that Michael Greiner, senior vice president and chief financial officer, will present at the Virtual Raymond James 42nd Annual Institutional Investors Conference on March 1 at approximately 3:50 p.m., ET. A live webcast of the presentation will be available on Avanos' Investors section and archived on their website.
Avanos Medical reported Q4 2020 net sales of $185 million, down 3% year-over-year, while full-year sales rose 3% to $715 million. The Q4 net loss was $47 million, compared to a loss of $6 million last year. Adjusted net income for the quarter was $13 million, down from $16 million a year ago. The company implemented a restructuring program projected to yield $7 million in annual savings. Notably, the restructuring led to an overall charge of $25-$30 million. Despite pandemic challenges, the company aims for growth and margin improvement in 2021.
Avanos Medical (NYSE: AVNS) will hold a conference call on Feb. 18, 2021, at 9 a.m. ET, to discuss its fourth quarter and full-year 2020 financial results. A news release detailing these results will be issued before market open that day. The call will be hosted by CEO Joe Woody and CFO Michael Greiner. Investors can join the call by dialing 877-240-5772 or access a live webcast via the Avanos Medical website. A replay will be available starting Feb. 18 at noon ET for one week.
Avanos Medical (NYSE: AVNS) will have CEO Joe Woody present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at approximately 2 p.m. ET. This presentation will be available via a live webcast, including a Q&A session, accessible through the Investors section of Avanos Medical's website and will be archived for later viewing. The company focuses on innovative healthcare solutions aimed at reducing opioid use and improving patient recovery.
Avanos Medical, Inc. (NYSE: AVNS) will present at two virtual investor conferences in November 2020. The Stifel 2020 Virtual Healthcare Conference will take place on Nov. 18 at 10 a.m. ET, featuring CEO Joe Woody. The Stephens Annual Investment Conference is scheduled for Nov. 19 at 8 a.m. ET, with CFO Michael Greiner speaking. Investors can access webcasts of both presentations on the Investors section of the Avanos Medical website. The company focuses on breakthrough medical device solutions to improve patient quality of life.
Avanos Medical reported third quarter 2020 net sales of $186 million, an 8% increase year-over-year. The company achieved a net income of $19 million, rebounding from a loss of $12 million last year. Despite challenges from the pandemic, demand for Respiratory Health products drove growth. Adjusted EBITDA was $24 million, slightly down from $25 million a year ago. The company continues to manage expenses effectively while investing in growth. However, it anticipates ongoing uncertainty due to COVID-19's impact on elective procedures.
Avanos Medical, Inc. (NYSE: AVNS) will hold a conference call on November 3, 2020, at 9 a.m. ET to discuss its third-quarter 2020 financial results. A news release detailing the financial results will be issued prior to the market opening on the same day. The call, hosted by CEO Joe Woody and CFO Michael Greiner, will be accessible via a live webcast on the Avanos Medical website. Replays will be available post-call on the same platform for one week.
FAQ
What is the current stock price of Avanos Medical (AVNS)?
What is the market cap of Avanos Medical (AVNS)?
